Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer

The aim of the present study was to verify whether the baseline circulating tumor cell (CTC) count might serve as a predictor of overall survival (OS) and metastasis-free survival (MFS) in patients with high-risk prostate cancer (PCa) during a follow-up period of at least 5 years. CTCs were enumerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieślikowski, Wojciech A., Milecki, Piotr, Świerczewska, Monika, Ida, Agnieszka, Kasperczak, Michał, Jankowiak, Agnieszka, Nowicki, Michał, Pantel, Klaus, Alix-Panabières, Catherine, Zabel, Maciej, Antczak, Andrzej, Budna-Tukan, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144132/
https://www.ncbi.nlm.nih.gov/pubmed/37108995
http://dx.doi.org/10.3390/jpm13040608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144132/
https://www.ncbi.nlm.nih.gov/pubmed/37108995
http://dx.doi.org/10.3390/jpm13040608

Ejemplares similares